XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Mar. 31, 2016
Mar. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (1,011,857) $ (1,003,372)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 171,592 381,406
Professional fee expenses paid with equity, including amortization of deferred expenses for prior period issuances 19,000 41,342
Compensation expenses paid with common shares and other equity 139,593 202,776
Amortization of discount on convertible debentures 248,204 274,755
Amortization of discount on notes payable 46,862 145,229
Bad debt and other expenses 186,556 112,642
Net cash (used in) provided by operating activities, before changes in current assets and liabilities other than cash (200,050) 154,778
Changes in current assets and liabilities other than cash:    
Decrease (increase) in accounts receivable 52,870 (168,009)
Decrease (increase) in prepaid expenses 11,531 (19,455)
(Increase) decrease in inventories and other current assets (10,657) 5,322
Increase in accounts payable, accrued liabilities and amounts due to directors and officers 193,132 405,873
(Decrease) increase in deferred revenue (41,050) 29,661
Net cash provided by operating activities 5,776 408,170
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisition of property and equipment (52,496) (201,504)
Net cash (used in) investing activities (52,496) (201,504)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of ownership interests in Variable Interest Entity, net of expenses 2,161,867 931,110
Proceeds from notes payable, net of expenses 157,000 42,570
Proceeds from convertible debentures, net of expenses 17,000 23,783
Distributions to owners of Variable Interest Entity (364,976) (33,333)
Repayment of notes and leases payable (517,662) (450,236)
Repayment of convertible debentures (1,438,000) (421,746)
Net cash provided by financing activities 15,229 92,148
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (31,491) 298,814
CASH AND CASH EQUIVALENTS, beginning of period 316,887 389,015
CASH AND CASH EQUIVALENTS, end of period 285,396 687,829
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:    
Cash payments for interest 355,726 500,610
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Issuance of common shares for consultant services 37,999 75,600
Issuance of common shares for employee services   48,750
Issuance of common shares for financing fees $ 63,425 30,500
Issuance of Sigma Note upon cancellation of Sigma Notes 1 and 2   $ 1,358,000